Literature DB >> 34050864

Defects in Protein Folding and/or Quality Control Cause Protein Aggregation in the Endoplasmic Reticulum.

Juthakorn Poothong1, Insook Jang1, Randal J Kaufman2.   

Abstract

Protein aggregation is now a common hallmark of numerous human diseases, most of which involve cytosolic aggregates including Aβ (AD) and ⍺-synuclein (PD) in Alzheimer's disease and Parkinson's disease. However, it is also evident that protein aggregation can also occur in the lumen of the endoplasmic reticulum (ER) that leads to specific diseases due to loss of protein function or detrimental effects on the host cell, the former is inherited in a recessive manner where the latter are dominantly inherited. However, the mechanisms of protein aggregation, disaggregation and degradation in the ER are not well understood. Here we provide an overview of factors that cause protein aggregation in the ER and how the ER handles aggregated proteins. Protein aggregation in the ER can result from intrinsic properties of the protein (hydrophobic residues in the ER), oxidative stress or nutrient depletion. The ER has quality control mechanisms [chaperone functions, ER-associated protein degradation (ERAD) and autophagy] to ensure only correctly folded proteins exit the ER and enter the cis-Golgi compartment. Perturbation of protein folding in the ER activates the unfolded protein response (UPR) that evolved to increase ER protein folding capacity and efficiency and degrade misfolded proteins. Accumulation of misfolded proteins in the ER to a level that exceeds the ER-chaperone folding capacity is a major factor that exacerbates protein aggregation. The most significant ER resident protein that prevents protein aggregation in the ER is the heat shock protein 70 (HSP70) homologue, BiP/GRP78, which is a peptide-dependent ATPase that binds unfolded/misfolded proteins and releases them upon ATP binding. Since exogenous factors can also reduce protein misfolding and aggregation in the ER, such as chemical chaperones and antioxidants, these treatments have potential therapeutic benefit for ER protein aggregation-associated diseases.

Entities:  

Keywords:  Amyloid; BiP/GRP78; CANX/CALR; CFTR; Clotting factor VIII; Proinsulin; UPR

Mesh:

Substances:

Year:  2021        PMID: 34050864      PMCID: PMC8802734          DOI: 10.1007/978-3-030-67696-4_6

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  135 in total

1.  Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response.

Authors:  Tunda Hidvegi; Bela Z Schmidt; Pamela Hale; David H Perlmutter
Journal:  J Biol Chem       Date:  2005-09-23       Impact factor: 5.157

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 3.  N-linked sugar-regulated protein folding and quality control in the ER.

Authors:  Abla Tannous; Giorgia Brambilla Pisoni; Daniel N Hebert; Maurizio Molinari
Journal:  Semin Cell Dev Biol       Date:  2014-12-19       Impact factor: 7.727

4.  The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo.

Authors:  M F Pelletier; A Marcil; G Sevigny; C A Jakob; D C Tessier; E Chevet; R Menard; J J Bergeron; D Y Thomas
Journal:  Glycobiology       Date:  2000-08       Impact factor: 4.313

5.  GRP78 overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice.

Authors:  T Teodoro-Morrison; I Schuiki; L Zhang; D D Belsham; A Volchuk
Journal:  Diabetologia       Date:  2013-03-09       Impact factor: 10.122

Review 6.  Cystic fibrosis transmembrane conductance regulator (ABCC7) structure.

Authors:  John F Hunt; Chi Wang; Robert C Ford
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

Review 7.  Structure and function of the CFTR chloride channel.

Authors:  D N Sheppard; M J Welsh
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

Review 8.  Calcium homeostasis and ER stress in control of autophagy in cancer cells.

Authors:  Elżbieta Kania; Beata Pająk; Arkadiusz Orzechowski
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

Review 9.  Quality control: ER-associated degradation: protein quality control and beyond.

Authors:  Annamaria Ruggiano; Ombretta Foresti; Pedro Carvalho
Journal:  J Cell Biol       Date:  2014-03-17       Impact factor: 10.539

10.  Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.

Authors:  Erik A Blackwood; Khalid Azizi; Donna J Thuerauf; Ryan J Paxman; Lars Plate; Jeffery W Kelly; R Luke Wiseman; Christopher C Glembotski
Journal:  Nat Commun       Date:  2019-01-14       Impact factor: 17.694

View more
  1 in total

Review 1.  Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator.

Authors:  Zhu Zhang; Ken Kin-Lam Yung; Joshua Ka-Shun Ko
Journal:  Antioxidants (Basel)       Date:  2022-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.